Telix Pharmaceuticals Ltd
ASX:TLX
Telix Pharmaceuticals Ltd
ASX:TLX
Price:
14.97 AUD
-0.53%
Market Closed
Updated:
May 7, 2024
Telix Pharmaceuticals Ltd
Cash from Financing Activities
|
Telix Pharmaceuticals Ltd
Cash from Financing Activities Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
PYC
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Cash from Financing Activities
AU$10.2m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immutep Ltd
ASX:IMM
|
Cash from Financing Activities
AU$76m
|
CAGR 3-Years
15%
|
CAGR 5-Years
29%
|
CAGR 10-Years
19%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Cash from Financing Activities
$67.8m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Cash from Financing Activities
-$1.6B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-8%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Cash from Financing Activities
-AU$2.7m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Cash from Financing Activities
AU$28.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
27%
|
CAGR 10-Years
22%
|
See Also
What is Telix Pharmaceuticals Ltd's Cash from Financing Activities?
Cash from Financing Activities
10.2m
AUD
10.2m
AUD
Based on the financial report for Dec 31, 2023, Telix Pharmaceuticals Ltd's Cash from Financing Activities amounts to 10.2m AUD.
What is Telix Pharmaceuticals Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-33%
-33%
Over the last year, the Cash from Financing Activities growth was -94%. The average annual Cash from Financing Activities growth rates for Telix Pharmaceuticals Ltd have been -33% over the past three years .
You don't have any saved screeners yet
